Ignite Creation Date:
2025-12-24 @ 4:26 PM
Ignite Modification Date:
2026-02-02 @ 4:51 AM
Study NCT ID:
NCT02365766
Status:
COMPLETED
Last Update Posted:
2025-03-18
First Post:
2015-02-11
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects
Sponsor:
Jason R. Brown
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-05-27
Start Date Type:
ACTUAL
Primary Completion Date:
2020-08-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-02-23
Completion Date Type:
ACTUAL
First Submit Date:
2015-02-11
First Submit QC Date:
None
Study First Post Date:
2015-02-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2024-08-30
Results First Submit QC Date:
None
Results First Post Date:
2025-03-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-27
Last Update Post Date:
2025-03-18
Last Update Post Date Type:
ACTUAL